The IPO found “MEVIA” should be cancelled based on the
following reasons:
1. First
of all, “NIVEA” is a famous trademark. Records shows that BEIERSDORF has been
using “NIVEA” for more than 100 years. In as early as 1905, BEIERSDORF had
registered “NIVEA” for its sunscreen and body lotion product, and its first NIVEA
trademark was registered with Taiwan’s IPO in 1970. Through its continuous use,
NIVEA has become a famous trademark for skin care products prior to the filing
date of “MEVIA” trademark (June 6, 2017).
2. Besides, NIVEA and MEVIA
are similar. Both trademarks present the combination of characters “E”, “V”,
“I”, and “A”, with different initial character and different sequence. Such
differences are minor, and a consumer with ordinary degree of care may still
find the two trademarks similar.
3. Further, NIVEA is highly
distinctive, because it bears no relation with its designated goods such as
body cleansing, beauty or cosmetic products. Comparing with MEVIA, NIVEA is
more famous and should be given more favorable light when it comes to
protectability.
4. In
addition, there is evidence showing that BEIERSDORF has expanded its
business to medical product like medical bandage, ointment, etc., and acquired
numerous trademark registrations for similar goods under class 5. Thus, there
is likelihood that consumers may mistakenly believe that the two trademarks
represent the same product, or there exists license or other business
relationship between BEIERSDORF and CONVATEC.
In light of the above, the IPO found for “NIVEA”
and ruled that “MEVIA” should be cancelled.
沒有留言:
張貼留言